| Net income | $8.7 million | $9.4 million in Q2; $6.8 million year
ago | Up 28% year over year |
| Diluted EPS | $0.35 | $0.38 in Q2; $0.28 year ago | Operating EPS also $0.35 |
| Operating ROA | 0.80% | 0.53% in Q2; 0.70% year ago | Mortgage breakeven would have lifted ROA to about 1%, according to
management |
| Pretax pre-provision operating income | $12.0 million | $8.7 million year ago | Up 38% year over year |
| Net interest income | $36.3 million | $33.8 million in Q2; $29.0 million year
ago | Included $700,000 of interest recoveries |
| Net interest margin | 3.66% | 3.45% in Q2; 3.18% year ago | Core NIM was 3.59% excluding the recovery |
| Loans held for investment | Approximately $3.5 billion | Up 4% annualized sequentially; up 9% year
over year | Panacea loans rose to $603 million |
| Total deposits | $3.47 billion | Up $26 million sequentially; up 4% year
over year | Total deposit cost was 2.28% |
| Provision for credit losses | $1.1 million | $5.5 million in Q2 | Mainly driven by loan growth |
| Nonperforming assets / total assets | 1.43% | 1.45% in Q2; 2.07% year ago | Excludes SBA-guaranteed portions |
| Noninterest income | $12.9 million | $22.0 million in Q2 | Q2 included a $5.9 million investment gain |
| Noninterest expense | $37.2 million | $38.2 million in Q2; $32.3 million year
ago | Core operating burden was approximately $24.2 million |
| Tangible book value per share | $13.81 | Up 18% year over year | TCE ratio improved to 8.14% |